Dexcom | DXCM - 贸易债权人



金融业
股票价格
USD
资产
USD 6.46B
现金及等价物
USD 1.11B
销售成本
USD 478.4M
流动资产
USD 4.09B
流动负债
USD 2.36B
债务
USD 1.24B
EBIT
USD 318.3M
EBITDA
USD 364.5M
员工
10.3K
EPS每股收益
USD 0.7
股本和储备
USD 2.62B
销售毛利
USD 750.3M
债务利息支出
USD 3.1M
利息收入
USD 19.5M
贷款资金
USD 1.3B
市值
USD 34.79B
净收入
USD 249.1M
营业费用
USD 990.1M
营业利润
USD 318.3M
普通股股本
USD 377.4M
PE价格收益
24.61
税前利润
USD 269.5M
销售收入
USD 1.31B
销售和管理费用
USD 358.7M
股票
USD 726.4M
贸易债权人
USD 2.08B
应收帐款人
USD 1.27B


贸易债权人 更改 日
Abbott USD 4.68B 439M 2026-03
Align Technology USD 109.84M 13.88M 2026-06
AtriCure USD 78.74M 8.68M 2026-06
Baxter International USD 1.03B 52M 2026-06
Becton, Dickinson and Co. USD 6.11B 173M 2026-06
Boston Scientific USD 1.23B 90M 2026-06
Cooper Companies USD 233.3M 7.5M 2026-03
Dexcom USD 2.08B 134.8M 2026-06
Edwards Lifesciences USD 210.5M 29.4M 2026-06
Globus Medical USD 106.94M 3.28M 2026-06
Inogen USD 21.22M 684K 2025-09
Insulet USD 123.3M 26.5M 2026-06
Integra LifeSciences USD 82.64M 5.31M 2026-06
J&J USD 9.22B 1.24B 2026-06
Medtronic USD 2.57B 12M 2025-12
Merit Medical Systems USD 70.74M 2.88M 2026-06
Roche Holding CHF 5.54B 237M 2026-06
Solventum Corp USD 701M 2M 2026-06
Stryker USD 1.59B 207M 2026-03
Tandem Diabetes Care USD 64.13M 4.27M 2026-06
Teleflex USD 143.29M 335K 2026-06
West Pharmaceutical Services USD 252.7M 400K 2026-06
Zimmer Biomet Holdings USD 352.4M 8.8M 2026-06